 Home > Active Ingredient News > Antitumor Therapy > JAMA Surg: The impact of liver transplantation vs. portal vein thrombosis after liver resection on the survival of colon cancer patients with liver metastases with high tumor burden

JAMA Surg: The impact of liver transplantation vs. portal vein thrombosis after liver resection on the survival of colon cancer patients with liver metastases with high tumor burden

 Last Update: 2021-04-17
 Source: Internet
 Author: User

Tags

sheep liver

manufacturing time study

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In Western countries, colorectal cancer is the second most common tumor.

Colorectal cancer

Recently, researchers compared the overall survival rate (OS) of LR after liver transplantation or PVE for patients with colorectal cancer and liver metastases with high tumor burden .

Recently, researchers compared the overall survival rate (OS) of patients with colorectal cancer with high tumor burden and LR after receiving liver transplantation or PVE.

Fifty patients with liver metastases from colon cancer participated in the study.

Among the 53 patients in the PVE group, the average age was 61.

The 5-year OS rate in the liver transplantation group was 33.

Studies have found that for patients with liver metastases from colon cancer with high tumor burden, the 5-year survival rate after liver transplantation is much higher than that after portal vein embolization .

For patients with liver metastases from colon cancer with high tumor burden, the 5-year survival rate of patients after liver transplantation is much higher than that of patients with liver resection after portal vein thrombosis.

Original source:

Svein Dueland et al.

com/journals/jamasurgery/article-abstract/2777911" target="_blank" rel="noopener">Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases.
JAMA is here to leave a message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Desmethyl Imatinib 99%

CAS No.: 404844-02-6

Pharma Grade

$1/MT FOB

Topotecan HCl CAS 119413-54-6 for Scientific Research Chemical Reagents Use only topetecan hydrochloride

CAS No.: 119413-54-6

Pharmacy Grade

$4-5/G FOB

Regorafenib 98% white powder 755037-03-7 Regorafenib (BAY 73-4506)

CAS No.: 755037-03-7

Pharmacy Grade

$4-5/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.